The target-oriented treatment of breast cancer is a precise and effective treatment that intervenes against specific molecular targets in breast cancer cells and aims at curbing the growth and spread of tumours. The following is a detailed analysis of the treatment of breast cancer:
I. The rationale for targeting treatment
Target-treated drugs can act specifically on the tumour cell surface or on specific internal molecular targets, which are usually specific to or overexpressed by the tumour cell. By combining these targets, drugs can disrupt the growth, fragmentation and survival of tumour cells and thus serve the purpose of treatment.
II. Application of target-oriented treatment
In the case of breast cancer, the target-oriented treatment is mainly applied to patients who are positive with HeR-2 (human skin growth factor receptor-2). Her-2 is a gene that leads to the dysentery of breast cancer, which tends to lead to poor prognosis of patients who increase or overexpression. Targeting treatment for Her-2 is therefore important in breast cancer treatment.
III. Targeting treatment drugs
(b) Curtorball monotron: This is an antibody drug for Her-2, which is uniquely combined with Her-2 receptor and inhibits the growth and spread of tumour cells. Curtoric monovalents can be used both individually and in combination with chemotherapy to improve treatment effectiveness. Pato-Choose: Another antibody drug for Her-2 has a similar mechanism to that of tuto-Choose, but the two can be used together to further enhance treatment effectiveness.
Small molecular TKI-type drugs, such as gilled carrotini, Tokatini etc., are inhibitors of chesysine accelerase that can inhibit the signaling of receptors such as Her-2, thus inhibiting the growth of tumour cells.
Target treatment has achieved significant results in breast cancer treatment. For HeR-2-positive breast cancer patients, targeted treatment can significantly increase the survival rate of patients and prolong the period of non-progress. Targeting treatments are more selective and targeted than traditional chemotherapy, with smaller damage to normal cells and therefore relatively few side effects.
V. Target treatment attention
Individualized treatment: Target-oriented treatment needs to be tailored to the specific circumstances of the patient to ensure treatment effectiveness and reduce side effects.
Monitoring of the heart function: Some of the target-oriented therapeutic drugs (e.g., anti-curvatures) may have toxic effects on the heart, so patients need to monitor the heart function on a regular basis.
Regular follow-up: During treatment, patients are required to follow up and review on a regular basis to assess the effectiveness of treatment and to monitor the occurrence of side effects.
Note the interaction of drugs: In the use of target-to-treatment drugs, patients need to be aware of the interaction between drugs and avoid the simultaneous use of drugs that may have adverse effects.
VI. Looking ahead to treatment
Target treatment will become increasingly important in the treatment of breast cancer as research on various targets for breast cancer continues and new target-to-pharmaceutical drugs are being developed. In the future, target-oriented treatment may be more closely integrated with other treatment methods (e.g. surgery, chemotherapy, treatment, etc.) to develop a better system of treatment that provides more accurate and effective treatment for patients.
In general, the target-oriented treatment of breast cancer is a promising treatment that intervenes against specific molecular targets of tumour cells, with the advantages of efficiency, low toxicity and low side effects. Targeting treatment will play an increasingly important role in future breast cancer treatment.
